Clinical Trials Directory

Trials / Completed

CompletedNCT02023229

Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis

High-fiber High-fiber Diet and Branched Chain Aminoacids. Impact on Nutritional Status and Complications in Patients With Liver Cirrhosis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Malnutrition is a frequent complication in patients with liver cirrhosis. Most patients have decreased dietary intake due to ascites, hepatic encephalopathy and pro-inflammatory cytokines. We hypothesized that branched chain aminoacids can improve nutritional status and delay episodes of hepatic encephalopathy

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBranched-chain aminoacids
OTHERHigh-fiber high protein diet

Timeline

Start date
2011-01-01
Primary completion
2013-01-01
Completion
2013-05-01
First posted
2013-12-30
Last updated
2013-12-30

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT02023229. Inclusion in this directory is not an endorsement.

Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis (NCT02023229) · Clinical Trials Directory